Industry News
New Nanoparticle Chemo Is Gentler On Fertility
Mar 25, 2013
Using nanoparticles as "Trojan horses", scientists have designed and lab-tested a way to deliver an arsenic-based chemo drug that ferociously attacks cancer, but is gentler on the ovaries. They hope the new method will help to protect the fertility of women undergoing cancer treatment... Read More
Researchers Study Use Of Dasatinib For Patients With High-Risk Myelodysplastic Syndromes
Mar 25, 2013
Researchers at Moffitt Cancer Center have completed a phase II clinical trial to determine the safety and efficacy of dasatinib for patients with higher-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia, or acute myeloid leukemia resulting from MDS and have failed treatment with azanucleosides... Read More
Drug Shortages Erode The Quality And Increase The Cost Of Cancer Care
Mar 25, 2013
A national survey of health professionals showed that drug shortages are taking a heavy toll on cancer patients, forcing treatment changes and delays that for some patients meant worse outcomes, more therapy-related complications and higher costs. St. Jude Children's Research Hospital investigators played an important role in the study... Read More
Young, Black, Female Breast Cancer Patients Need Genetic Risk Strategies
Mar 25, 2013
Researchers at Moffitt Cancer Center and colleagues in Canada have published study results focused on black women younger than 50, a population disproportionately afflicted with and dying from early-onset breast cancer compared to their white counterparts. The research published in The Breast Journal. Early-onset breast cancer has been associated with mutations in the BRCA1 and BRCA2 genes... Read More
Risk Factors In Prostate Cancer: Genetics, Age And Ethnicity
Mar 25, 2013
"Are there genetic risk factors for PCa? Yes, and BRCA2 and HOXB13 are useful for predicting high-risk disease," said Jack Cuzick (GB) president of the International Society for Cancer Prevention (ISCaP), referring to the two genes implicated in high-risk prostate disease... Read More
Immunotherapeutic Approach To Melanoma Treatment Shows Promise
Mar 25, 2013
Scientists have characterized how the functionality of genetically engineered T cells administered therapeutically to patients with melanoma changed over time... Read More
High Vitamin D Helps Healthy People Stay That Way
Mar 25, 2013
Healthy people with higher vitamin D levels in their blood may enjoy several benefits, apart from improved bone health, researchers from Boston University School of Medicine reported in PLOS ONE... Read More
Genetic Alterations Linked With Bladder Cancer Risk, Recurrence, Progression, And Patient Survival
Mar 25, 2013
A new analysis has found that genetic alterations in a particular cellular pathway are linked with bladder cancer risk, recurrence, disease progression, and patient survival. Published early online in CANCER, a peer- reviewed journal of the American Cancer Society, the findings could help improve bladder cancer screening and treatment... Read More
Expanding Blood Stem Cells For Bone Marrow Transplant - New Method Developed
Mar 25, 2013
Scientists at Weill Cornell Medical College believe they have solved how to expand adult hematopoietic stem cells (HSCs) outside the human body for medical use in bone marrow transplantation - a vital step towards being able to produce enough stem cells required to re-establish a healthy blood system... Read More
Novel Method Points To New Blood Tests For Conditions From Autoimmune Diseases To Alzheimer's
Mar 25, 2013
Researchers at The Scripps Research Institute (TSRI) in Jupiter, FL, have developed cutting-edge technology that can successfully screen human blood for disease markers. This tool may hold the key to better diagnosing and understanding today's most pressing and puzzling health conditions, including autoimmune diseases... Read More
Previous Page Next Page